This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Vinblastine and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (8)
Death (3)
Disability (2)
Reports by Reaction Type
Pancytopenia (4),
Streptococcal Bacteraemia (3),
Renal Failure Acute (3),
Vomiting (3),
Nausea (3),
Carbon Monoxide Diffusing Capacity Decreased (3),
Febrile Neutropenia (3),
Coordination Abnormal (2),
Peripheral Sensorimotor Neuropathy (2),
Hypoaesthesia (2),
Paraesthesia (2),
Gait Disturbance (2)
Possible Vinblastine side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-27
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Carboplatin
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Cisplatin
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Cytarabine
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Dacarbazine
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Dexamethasone Sodium Phosphate
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Doxorubicin HCL
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Doxorubicin HCL
Dosage: unk
Indication: Hodgkin's Disease
Etoposide
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Etoposide
Dosage: unk
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Gemcitabine Hydrochloride
Dosage: unk
Indication: Hodgkin's Disease
Start date: 2007-01-01
Ifosfamide
Dosage: unk
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Rituximab
Dosage: unk
Indication: Hodgkin's Disease
Start date: 2007-01-01
Vinblastine
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Vinorelbine
Dosage: unk
Indication: Hodgkin's Disease
Start date: 2007-01-01
Possible Vinblastine side effects in 28 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-11
Patient: 28 year old female
Reactions: Streptococcal Bacteraemia, Vomiting, Nausea, Peripheral Sensorimotor Neuropathy, Carbon Monoxide Diffusing Capacity Decreased, Pancytopenia, Febrile Neutropenia, Hypoaesthesia, Paraesthesia, Gait Disturbance, Coordination Abnormal, Renal Failure Acute
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: 15 units/m2 over 24h on day2
Cisplatin
Dosage: 45 mg/m2, unk
Cisplatin
Dosage: 90 mg/m2, over 4h on day1
Indication: Ovarian Cancer
Cyclophosphamide
Dosage: 750 mg/m2, unk
Cyclophosphamide
Dosage: 1000 mg/m2, over 60min on day 2
Indication: Ovarian Cancer
Doxorubicin HCL
Dosage: 30 mg/m2, unk
Doxorubicin HCL
Dosage: 45 mg/m2, over 30min on day3
Indication: Ovarian Cancer
Etoposide
Dosage: 200 mg/m2, over 2h on day3
Indication: Ovarian Cancer
Etoposide
Dosage: 100 mg/m2, unk
Vinblastine
Dosage: 6 mg/m2, over 30 minutes on day 1
Indication: Ovarian Cancer
Other drugs received by patient: Pegfilgrastim
Possible Vinblastine side effects in 28 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29
Patient: 28 year old female
Reactions: Streptococcal Bacteraemia, Vomiting, Nausea, Peripheral Sensorimotor Neuropathy, Carbon Monoxide Diffusing Capacity Decreased, Pancytopenia, Febrile Neutropenia, Hypoaesthesia, Paraesthesia, Coordination Abnormal, Gait Disturbance, Renal Failure Acute
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Bleomycin
Dosage: 15 units/m2 over 24h on day2
Cisplatin
Dosage: 90 mg/m2 over 4h on day1
Indication: Ovarian Cancer
Cisplatin
Dosage: 45 mg/m 2
Cyclophosphamide
Dosage: 1000 mg/m2 over 60min on day 2
Indication: Ovarian Cancer
Cyclophosphamide
Dosage: 750 mg/m 2
Doxorubicin HCL
Dosage: 45 mg/m2 over 30min on day3
Indication: Ovarian Cancer
Doxorubicin HCL
Dosage: 30 mg/m 2
Etoposide
Dosage: 200 mg/m2 over 2h on day3
Indication: Ovarian Cancer
Etoposide
Dosage: 100 mg/m 2
Vinblastine
Dosage: 6mg/m2 over 30min on day1
Indication: Ovarian Cancer
Other drugs received by patient: Pegfilgrastim
Possible Vinblastine side effects in 28 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-04
Patient: 28 year old female
Reactions: Streptococcal Bacteraemia, Vomiting, Nausea, Carbon Monoxide Diffusing Capacity Decreased, Febrile Neutropenia, Pancytopenia, Neuropathy Peripheral, Bacteraemia, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bleomycin Sulfate
Bleomycin Sulfate
Bleomycin Sulfate
Indication: Ovarian Cancer
Bleomycin Sulfate
Cisplatin
Indication: Ovarian Cancer
Cisplatin
Cisplatin
Cisplatin
Cisplatin
Cisplatin
Cyclophosphamide
Indication: Ovarian Cancer
Cyclophosphamide
Cyclophosphamide
Cyclophosphamide
Cyclophosphamide
Cyclophosphamide
Doxorubicin HCL
Dosage: cycle 5
Indication: Ovarian Cancer
Doxorubicin HCL
Dosage: cycle 3
Doxorubicin HCL
Dosage: cycle 6
Doxorubicin HCL
Dosage: cycle 1
Doxorubicin HCL
Dosage: cycle 2
Doxorubicin HCL
Dosage: cycle 4
Etoposide
Etoposide
Indication: Ovarian Cancer
Etoposide
Etoposide
Etoposide
Etoposide
Vinblastine
Indication: Ovarian Cancer
Vinblastine Sulfate
Vinblastine Sulfate
Vinblastine Sulfate
Vinblastine Sulfate
Vinblastine Sulfate
Other drugs received by patient: Pegfilgrastim; Pegfilgrastim; Pegfilgrastim; Pegfilgrastim; Pegfilgrastim; Pegfilgrastim
Possible Vinblastine side effects in
Reported by a physician from Italy on 2012-05-04
Patient:
Reactions: Death, Hodgkin's Disease Recurrent, Lung Disorder, Pulmonary Embolism, Treatment Failure, Lymphoma, Hodgkin's Disease
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Doxorubicin HCL
Indication: Hodgkin's Disease
Doxorubicin HCL
Epirubicin Hydrochloride
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Lomustine
Indication: Hodgkin's Disease
Mechlorethamine
Indication: Hodgkin's Disease
Prednisone TAB
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Indication: Hodgkin's Disease
Vinblastine
Indication: Hodgkin's Disease
Vincristine Sulfate
Indication: Hodgkin's Disease
Vindesine
Indication: Hodgkin's Disease
Possible Vinblastine side effects in 24 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-04
Patient: 24 year old female
Reactions: Mucosal Inflammation, Cellulitis, Pancytopenia
Drug(s) suspected as cause:
Bleomycin Sulfate
Bleomycin Sulfate
Bleomycin Sulfate
Bleomycin Sulfate
Bleomycin Sulfate
Indication: Ovarian Cancer
Bleomycin Sulfate
Cisplatin
Cisplatin
Cisplatin
Cisplatin
Cisplatin
Indication: Ovarian Cancer
Cisplatin
Cyclophosphamide
Indication: Ovarian Cancer
Cyclophosphamide
Cyclophosphamide
Cyclophosphamide
Cyclophosphamide
Cyclophosphamide
Doxorubicin HCL
Dosage: cycle 4
Doxorubicin HCL
Dosage: cycle 6
Doxorubicin HCL
Dosage: cycle 3
Doxorubicin HCL
Dosage: cycle 2
Doxorubicin HCL
Dosage: cycle 1
Indication: Ovarian Cancer
Doxorubicin HCL
Dosage: cycle 5
Etoposide
Etoposide
Etoposide
Etoposide
Etoposide
Indication: Ovarian Cancer
Etoposide
Vinblastine
Vinblastine
Vinblastine
Vinblastine
Vinblastine
Indication: Ovarian Cancer
Vinblastine
Other drugs received by patient: Pegfilgrastim; Pegfilgrastim; Pegfilgrastim; Pegfilgrastim; Pegfilgrastim; Pegfilgrastim
Possible Vinblastine side effects in 50 year old male
Reported by a physician from Greece on 2012-05-02
Patient: 50 year old male
Reactions: Multi-Organ Failure, Toxicity To Various Agents
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Doxorubicin HCL
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Ifosfamide
Indication: Hodgkin's Disease
Mesna
Indication: Hodgkin's Disease
Mitoxantrone Hydrochloride
Vinblastine
Indication: Hodgkin's Disease
Possible Vinblastine side effects in
Reported by a physician from United States on 2012-02-08
Patient:
Reactions: Syndactyly, Maternal Exposure Timing Unspecified
Drug(s) suspected as cause:
Adriamycin PFS
Bleomycin
Dacarbazine
Vinblastine
|